Stereotactic Body Radiotherapy

Increased Risk of Noncancer Deaths Associated with Stereotactic Body Radiation Therapy for Lung Cancer

By

High doses of SBRT, particularly to the left atrium of the heart and the superior vena cava, are associated with a small but increased risk of death from noncancer causes in patients with early stage NSCLC.

SBRT Well Tolerated in Patients With Early Stage and Centrally Located NSCLC

By

Treatment with stereotactic body radiotherapy (SBRT) was well-tolerated by patients whose non-small cell lung cancer (NSCLC) tumors were located centrally in the chest and who were not candidates for surgery.

Interstitial lung disease raises risk of lung inflammation after stereotactic body radiation therapy (SBRT) for lung cancer

By

Pretreatment interstitial lung disease (ILD) is a significant risk factor for symptomatic and severe radiation pneumonitis in patients with stage I non-small cell lung cancer (NSCLC) who are treated with stereotactic body radiation therapy (SBRT) alone, according to a new study.

Can radiation therapy help  resolve the  liver cancer 'paradox'?

Can radiation therapy help resolve the liver cancer 'paradox'?

By

Few patients with HCC are candidates for curative treatment at diagnosis. However, a new study demonstrated that stereotactic body radiotherapy...

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs